Webinar: Introducing ILDsym, a New Tool to Facilitate Development of Drugs to Treat Interstitial Lung Disease

Webinar: Introducing ILDsym, a New Tool to Facilitate Development of Drugs to Treat Interstitial Lung Disease

  Wednesday, April 20, 2022  8:00- 9:00 AM PDT  Speakers: Lisl Shoda and Zack Kenz Systemic sclerosis (SSc), also known as scleroderma, is a rare…

Read More

ASCPT Network & Community Experience

Scott Q Siler, Ph.D. is the Chief Scientific Officer of the DILIsym Services division of Simulations Plus. Dr. Siler will speak during the Systems Pharmacology…

Read More

Webinar: QST and the Transformation in Drug Safety Assessment

QST and the Transformation in Drug Safety Assessment Paul B. Watkins, M.D. FAASLD. Director, Institute for Drug Safety Sciences at the University of North Carolina…

Read More